A Medical Device Daily

MicroFluidic Systems (MFSI; Pleasanton, California), focused on the development of microfluidic systems for automated preparation of biological assays, reported that it has been awarded a Phase II continuation of its Bioagent Autonomous Networked Detector (BAND) System development contract by the Department of Homeland Security's (DHS) Homeland Security Advanced Research Projects Agency (HSARPA).

The Phase II continuation is expected to produce manufacturing prototypes of the proof-of-principal systems developed in the Phase I contract over the past 18 months at MFSI.

Phase II will lead to the third level of development, or Phase III, where additional systems will be built for testing as potential replacements for the nation's current BioWatch program. That project is coupled with its additional ongoing contract with HSARPA for the development of an instantaneous bioaerosol detection system and its stand-alone laboratory sample processing instruments including the BioLyser.

The company said applications for those technologies also include clinical diagnostics, emerging disease monitoring, industrial testing, forensics and research.

In other grants/contracts news:

• Radlink (Redondo Beach, California), a provider of medical imaging systems to healthcare, has signed an agreement with Clinical Image Management Systems (San Antonio) to serve as master distributor of its CR Pro machine to healthcare organizations in the states of Texas, Oklahoma, Kansas, Colorado and New Mexico, as well as the territory of Puerto Rico.

Earlier this year, Radlink was granted clearance by the FDA to proceed with the sale and distribution of its CR Pro machine. The system uses Radlink's sealed fiber-optic laser technology to deliver “diagnostic-quality images,“ the company said.

• MEDai (Orlando, Florida), a health information company offering solutions for the improvement of healthcare delivery, reported that Premier Health Partners (Dayton, Ohio) has signed a multiyear contract to utilize MEDai's Pinpoint Quality outcomes measurement system.

Premier Health Partners is comprised of three hospitals that include Good Samaritan Hospital , Miami Valley Hospital and Middletown Regional Hospital .

Pinpoint Quality is an outcomes measurement application designed to enable users to identify specific steps to monitor and improve clinical outcomes while reducing healthcare costs, the company said.